Abstract

Although the oncogene MMSET (also known as NSD2 or WHSC1) has an essential role in malignancies, its impact on human endometrial cancer (EC) metastasis and the molecular mechanism of MMSET regulation are largely unknown. We report that MMSET was markedly upregulated in EC cell lines and EC tissues, and was significantly associated with poor survival in EC. MMSET overexpression greatly promoted EC cell invasion and sphere formation, whereas inhibition of MMSET reduced EC cell invasion and sphere formation. Importantly, Twist1 was required for MMSET-induced EC cell invasion and sphere formation. Moreover, we demonstrate that miR-34a, miR-424 and miR-513 directly modulate MMSET expression to attenuate the invasion and sphere formation capacity of EC cells. miR-34a, miR-424 and miR-513 were down-regulated in EC compared with normal tissue, and reduced expression of miR-34a, miR-424 and miR-513 was clinically associated with a poorer prognosis in EC patients. Furthermore, specific inhibition of MMET with BIX-01294 led to decreased EC cell invasion and impaired sphere formation. These findings suggest a pro-metastatic role for MMSET in EC and reveal that the repression of miR-34a, miR-424 and miR-513 contributes to the overexpression of MMSET during EC metastasis.

Highlights

  • Metastasis causes > 90% of cancer-related deaths, our understanding of the molecular mechanisms that regulate endometrial cancer (EC) metastasis remains limited

  • When we compared mRNA expression between the EM and EC cells, we identified the upregulation of MMSET in the EC cell lines (Figure 1A)

  • Our results showed that MMSET-transfected Ishikawa cells formed more tumor spheres with higher cell content compared with the spheres formed by control cells (Figure 1D)

Read more

Summary

Introduction

Metastasis causes > 90% of cancer-related deaths, our understanding of the molecular mechanisms that regulate endometrial cancer (EC) metastasis remains limited. EMT can be induced by several transcription factors including Twist, which repress E-cadherin expression and increase levels of Vimentin. Elevated levels of Twist are associated with increased metastasis and poor survival in EC patients [4]. MMSET epigenetically activates Twist to promote EMT in prostate cancer [11]. MMSET is upregulated in EC through unknown mechanisms, and its overexpression has been correlated with higher grade, advanced stage and poorer patient survival [12]. MicroRNAs (miRNAs) serve as a class of oncogenes or tumor suppressors by binding to the 3′-untranslated region (UTR) of target mRNAs. little is known regarding the function of MMSET and the mechanisms underlying the regulation of its expression in EC

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call